Drug Database
Back to search

United Kingdom· GB-APID-20176611000001100

Cyanokit 5g powder for solution for infusion vials

A hydroxocobalamin product containing hydroxocobalamin, registered in United Kingdom by SERB. The same ATC class is registered in 11 of our 19 countries.

ATC B03BA03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCyanokit 5g powder for solution for i…ATCB03BA03REGISTER NO.GB-APID-2017661100000…PACKS LISTED4CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydroxocobalaminAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydroxocobalamin is registered in 11 of 19 countries.

Countries holding a registration under ATC B03BA03 (hydroxocobalamin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose
Search hydroxocobalamin products by name

Hydroxocobalamin · ATC B03BA03

11 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Hydroxocobalamin
Manufacturer
SERB
Country
United Kingdom (GB)
ATC code
B03BA03
ATC class
Hydroxocobalamin
Defined daily dose
20 mcg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 4

  • gtin
    05055956400225
  • gtin
    3596540240039
  • gtin
    5055956400027
  • gtin
    05055956400645

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for hydroxocobalamin.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydroxocobalamin against other medicinesHow interaction checks work

Hydroxocobalamin · interactions on record

40 records

  • 2 moderate
  • 38 info

Most severe, free to view

  • ChloramphenicolJ01BA01moderate
  • Arsenic trioxideL01XX27moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydroxocobalamin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxocobalamin products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Erycytol Depot
  • Belgium · Hydroxocobalamine Acetate Sterop
  • Cyprus · Articlox
  • Germany · Depogamma, Lophakomp-B 12-Depot
  • Denmark · Cohemin, Hydroxocobalamin Alternova
  • Spain · Hidroxocobalamina Basi, Megamilbedoce
  • Finland · Cohemin, Hydroxocobalamin G.L. Pharma
  • France · Dodecavit, Novobedouze
  • Greece · Articlox
  • Ireland · Hydroxocobalamin G.L. Pharma, Hydroxy-Vit
  • Iceland · Cyanokit, Hydroxocobalamin G.L. Pharma
  • Italy · Neo Cytamen
  • Liechtenstein · Cyanokit
  • Malta · Articlox
  • Netherlands · Hydrocobamine, Hydroxocobalamine Focus Care
  • Norway · Cyanokit, Hydroxocobalamin Basi
  • Portugal · Hidroxocobalamina Basi
  • Sweden · Hydroxocobalamin Alternova, Hydroxocobalamin G.L. Pharma
  • Slovenia · Hidroksokobalamin Orion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/946e8672-1e16-4876-a5c2-1f2b635b6624
GET /v1/drugs/946e8672-1e16-4876-a5c2-1f2b635b6624?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "20176611000001100",
  "desc": "Cyanokit 5g powder for solution for infusion vials (SERB)",
  "form": "Powder for solution for infusion",
  "vpid": "20177111000001106",
  "source": "dmd",
  "vtm_id": "776268009",
  "strength": "5 gram",
  "substance": "Hydroxocobalamin",
  "ingredient": "Hydroxocobalamin",
  "supplier_code": "21890711000001102"
}
API referenceMCP serverPlans

See everything about hydroxocobalamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console